LISPRO Side Effects

6938224-1 | Fall, Impaired Healing, Limb Injury, Osteitis
on Aug 11, 2010 Male patient from GERMANY , 48 years of age, was diagnosed with diabetes mellitus and was treated with Lispro (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), impaired healing, limb injury, osteitis. Lispro dosage: . During the same period patient was treated with HUMULIN R (View Humulin R Review and Humulin R Label ), PENTAERYTHRITOL TETRANITRATE (View Pentaerythritol Tetranitrate Review and Pentaerythritol Tetranitrate Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MOLSIDOMIN (View Molsidomin Review and Molsidomin Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), OMEP (View Omep Review and Omep Label ).

6906464-3 | Injection Site Pain
Patient was taking Lispro (View Usage). Patient had the following side effects: injection site pain on Jul 23, 2010 from GERMANY Additional patient health information: Female patient , weighting 114.6 lb, was diagnosed with diabetes mellitus and. Lispro dosage: 42 Ie, Five Times Daily. During the same period patient was treated with PROTAPHANE (View Protaphane Review and Protaphane Label ).

6888437-2 | Blood Glucose Increased, Cerebral Haemorrhage, Convulsion, Diabetic Ketoacidosis
Adverse event was reported on Jul 19, 2010 by a Female patient taking Lispro (View Usage) (Dosage: 10 Iu, 3/d) was diagnosed with diabetes mellitus, hypertension and. Location: JORDAN , weighting 132.3 lb, After Lispro was administered, patient had the following side effects: blood glucose increased, cerebral haemorrhage, convulsion, diabetic ketoacidosis. During the same period patient was treated with LANTUS (20 Iu, Unk) (View Lantus Review and Lantus Label ), GLUCOPHAGE (850 Mg, 2/d) (View Glucophage Review and Glucophage Label ), NORVASC (5 Mg, 2/d) (View Norvasc Review and Norvasc Label ), ASPIRIN (100 Mg, Daily (1/d)) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6766661-7 | Hypoglycaemia, Neuroglycopenia
on May 31, 2010 Female patient from SWITZERLAND , 44 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Lispro (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, neuroglycopenia. Lispro dosage: Unk, Other. During the same period patient was treated with INSULIN GLARGINE (View Insulin Glargine Review and Insulin Glargine Label ).


6473153-1 | Diabetic Ketoacidosis, Hypoglycaemia, Hypothermia, Renal Failure Acute, Rhabdomyolysis
on Sep 09, 2008 Male patient from JAPAN , 72 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Lispro (View Usage). Patient had the following side effects: diabetic ketoacidosis, hypoglycaemia, hypothermia (What is hypothermia?), renal failure acute, rhabdomyolysis. Lispro dosage: 8 Iu, Each Morning. During the same period patient was treated with HUMULIN N (10 Iu, Daily (1/d)) (View Humulin N Review and Humulin N Label ), AMLODIPINE (10 Mg, Unk) (View Amlodipine Review and Amlodipine Label ), CANDESARTAN CILEXETIL (8 Mg, Unk) (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), TRICHLORMETHIAZIDE (1 Mg, Unk) (View Trichlormethiazide Review and Trichlormethiazide Label ). Patient was hospitalized.

6472109-2 | Diabetic Ketoacidosis
Patient was taking Lispro (View Usage). After Lispro was administered, patient had the following side effects: diabetic ketoacidosis on Apr 01, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 150.0 lb, was diagnosed with type 1 diabetes mellitus and. Lispro dosage: 18 Iu, 3/d. During the same period patient was treated with INSULIN GLARGINE (26 Iu, Each Morning) (View Insulin Glargine Review and Insulin Glargine Label ). Patient was hospitalized.

6471285-5 | Diabetes Mellitus Inadequate Control, Diabetic Complication
Adverse event was reported on Jul 10, 2008 by a Female patient taking Lispro (View Usage) (Dosage: 26 Iu, Unk) was diagnosed with type 1 diabetes mellitus, prophylaxis, dysmenorrhoea and. Location: CROATIA (local name: Hrvatska) , weighting 169.8 lb, Patient experienced the following unwanted or unexpected effects: diabetes mellitus inadequate control, diabetic complication. During the same period patient was treated with INSULIN GLARGINE (15 Iu, Daily (1/d)) (View Insulin Glargine Review and Insulin Glargine Label ), TRANDOLAPRIL (View Trandolapril Review and Trandolapril Label ), ETHYLESTRENOL (View Ethylestrenol Review and Ethylestrenol Label ), VITAMINS NOS (View Vitamins Nos Review and Vitamins Nos Label ). Patient was hospitalized.

6471009-1 | Hypoglycaemia, Loss Of Consciousness
on Jan 17, 2008 Male patient from UNITED STATES , weighting 246.5 lb, was diagnosed with type 1 diabetes mellitus and was treated with Lispro (View Usage). Patient had the following side effects: hypoglycaemia, loss of consciousness. Lispro dosage: 26 Iu, Daily (1/d). During the same period patient was treated with INSULIN GLARGINE (70 Iu, Daily (1/d)) (View Insulin Glargine Review and Insulin Glargine Label ), ACETYLSALICYLIC ACID (81 Mg, Daily (1/d)) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), EZETIMIBE (10 Mg, Daily (1/d)) (View Ezetimibe Review and Ezetimibe Label ), SIMVASTATIN (40 Mg, Daily (1/d)) (View Simvastatin Review and Simvastatin Label ), FEXOFENADINE HCL (180 Mg, Daily (1/d)) (View Fexofenadine Hcl Review and Fexofenadine Hcl Label ), OMEPRAZOLE (20 Mg, Daily (1/d)) (View Omeprazole Review and Omeprazole Label ), RAMIPRIL (10 Mg, Daily (1/d)) (View Ramipril Review and Ramipril Label ).

6470247-1 | Cardiac Failure Congestive
on Jan 17, 2008 Male patient from CROATIA (local name: Hrvatska) , weighting 189.6 lb, was diagnosed with diabetes mellitus, angina pectoris, hyperlipidaemia and was treated with Lispro (View Usage). After Lispro was administered, patient had the following side effects: cardiac failure congestive. Lispro dosage: . During the same period patient was treated with ANDOL (100 Mg, Daily (1/d)) (View Andol Review and Andol Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), LESCOL (View Lescol Review and Lescol Label ). Patient was hospitalized.

6470187-8 | Diabetic Ketoacidosis
Patient was taking Lispro (View Usage). Patient experienced the following unwanted or unexpected effects: diabetic ketoacidosis on Dec 31, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 149.0 lb, was diagnosed with type 1 diabetes mellitus and. Lispro dosage: 18 Iu, Other. During the same period patient was treated with INSULIN GLARGINE (25 Iu, Each Morning) (View Insulin Glargine Review and Insulin Glargine Label ).

6469699-2 | Hypoglycaemia, Incorrect Dose Administered, Loss Of Consciousness
Adverse event was reported on Jun 29, 2009 by a Male patient taking Lispro (View Usage) (Dosage: 26 Iu, Daily (1/d)) was diagnosed with type 1 diabetes mellitus and. Location: UNITED STATES , weighting 246.5 lb, Patient had the following side effects: hypoglycaemia, incorrect dose administered, loss of consciousness. During the same period patient was treated with INSULIN GLARGINE (70 Iu, Daily (1/d)) (View Insulin Glargine Review and Insulin Glargine Label ), ACETYLSALICYLIC ACID (81 Mg, Daily (1/d)) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), EZETIMIBE (10 Mg, Daily (1/d)) (View Ezetimibe Review and Ezetimibe Label ), SIMVASTATIN (40 Mg, Daily (1/d)) (View Simvastatin Review and Simvastatin Label ), FEXOFENADINE HCL (180 Mg, Daily (1/d)) (View Fexofenadine Hcl Review and Fexofenadine Hcl Label ), OMEPRAZOLE (20 Mg, Daily (1/d)) (View Omeprazole Review and Omeprazole Label ).

6469238-6 | Cardio-respiratory Arrest, Diabetic Foot, Gangrene, Hypoglycaemia
on Feb 13, 2008 Female patient from INDIA , weighting 149.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with Lispro (View Usage). After Lispro was administered, patient had the following side effects: cardio-respiratory arrest, diabetic foot, gangrene, hypoglycaemia. Lispro dosage: 48 Iu, Daily (1/d). During the same period patient was treated with LANTUS (52 U, At Night) (View Lantus Review and Lantus Label ), METFORMIN HCL (500 Mg, 3/d) (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6468851-X | Diabetic Nephropathy, Pulmonary Oedema
on Jan 09, 2008 Female patient from SLOVENIA , 67 years of age, was treated with Lispro (View Usage). Patient experienced the following unwanted or unexpected effects: diabetic nephropathy, pulmonary oedema. Lispro dosage: . During the same period patient was treated with CIPROFLOXACIN (200 Mg, Daily (1/d)) (View Ciprofloxacin Review and Ciprofloxacin Label ), HEPARIN (View Heparin Review and Heparin Label ), INSULIN (View Insulin Review and Insulin Label ), CHOLESTEROL AND TRIGLYCERIDE REDUCERS (View Cholesterol- And Triglyceride Reducers Review and Cholesterol- And Triglyceride Reducers Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), PENTOXIFYLLINE (View Pentoxifylline Review and Pentoxifylline Label ). Patient was hospitalized.

6354674-9 | Hyperglycaemia
Patient was taking Lispro (View Usage). Patient had the following side effects: hyperglycaemia on Sep 02, 2009 from HONDURAS Additional patient health information: Female patient , 50 years of age, was diagnosed with type 2 diabetes mellitus and. Lispro dosage: Unk, 2/d. During the same period patient was treated with HUMULIN 70/30 (View Humulin 70/30 Review and Humulin 70/30 Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6297876-2 | Anaphylactic Reaction, Diabetic Ketoacidosis, Serum Sickness-like Reaction, Type Iii Immune Complex Mediated Reaction
Adverse event was reported on Jul 28, 2009 by a Female patient taking Lispro (View Usage) (Dosage: ) was diagnosed with type 1 diabetes mellitus, asthma (What is asthma?) and. Location: TURKEY , 26 years of age, After Lispro was administered, patient had the following side effects: anaphylactic reaction, diabetic ketoacidosis, serum sickness-like reaction, type iii immune complex mediated reaction. During the same period patient was treated with HUMULIN R (View Humulin R Review and Humulin R Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized.

6260532-0 | Hypoglycaemia, Loss Of Consciousness
on Jun 29, 2009 Male patient from UNITED STATES , weighting 246.5 lb, was diagnosed with type 1 diabetes mellitus and was treated with Lispro (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, loss of consciousness. Lispro dosage: 26 Iu, Daily (1/d). During the same period patient was treated with INSULIN GLARGINE (70 Iu, Daily (1/d)) (View Insulin Glargine Review and Insulin Glargine Label ), ASPIRIN (81 Mg, Daily (1/d)) (View Aspirin Review and Aspirin Label ), EZETIMIBE (10 Mg, Daily (1/d)) (View Ezetimibe Review and Ezetimibe Label ), SIMVASTATIN (40 Mg, Daily (1/d)) (View Simvastatin Review and Simvastatin Label ), FEXOFENADINE HYDROCHLORIDE (180 Mg, Daily (1/d)) (View Fexofenadine Hydrochloride Review and Fexofenadine Hydrochloride Label ), OMEPRAZOLE (20 Mg, Daily (1/d)) (View Omeprazole Review and Omeprazole Label ).

6249542-7 | Injection Site Abscess, Injection Site Erythema, Injection Site Hypersensitivity, Injection Site Pain, Skin Swelling
on Jun 22, 2009 Female patient from LEBANON , 47 years of age, weighting 127.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with Lispro (View Usage). Patient had the following side effects: injection site abscess, injection site erythema, injection site hypersensitivity, injection site pain, skin swelling. Lispro dosage: 35-20, 2/d. During the same period patient was treated with GLUCOPHAGE (2000 Mg, Daily (1/d)) (View Glucophage Review and Glucophage Label ). Patient was hospitalized.

6220088-5 | Injection Site Abscess, Injection Site Hypersensitivity, Injection Site Pain
Patient was taking Lispro (View Usage). After Lispro was administered, patient had the following side effects: injection site abscess, injection site hypersensitivity, injection site pain on May 27, 2009 from LEBANON Additional patient health information: Female patient , 47 years of age, weighting 127.9 lb, was diagnosed with type 2 diabetes mellitus and. Lispro dosage: 35-20, 2/d. During the same period patient was treated with GLUCOPHAGE (2000 Mg, Daily (1/d)) (View Glucophage Review and Glucophage Label ). Patient was hospitalized.

6145150-7 | Cardiomegaly, Hypersensitivity, Oedema, Pulmonary Oedema
Adverse event was reported on Mar 26, 2009 by a Female patient taking Lispro (View Usage) (Dosage: 30 Iu, Each Morning) was diagnosed with type 2 diabetes mellitus, hypertension and. Location: INDONESIA , weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: cardiomegaly, hypersensitivity, oedema, pulmonary oedema. During the same period patient was treated with INSULIN, HUMAN (View Insulin, Human Review and Insulin, Human Label ), VALSARTAN (80 Mg, Unk) (View Valsartan Review and Valsartan Label ), AMLODIPINE BESYLATE (5 Mg, Unk) (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ACETYLSALICYLATE CALCIUM (80 Mg, Unk) (View Acetylsalicylate Calcium Review and Acetylsalicylate Calcium Label ), SITAGLIPTIN (25 Mg, Unk) (View Sitagliptin Review and Sitagliptin Label ). Patient was hospitalized.

5889343-2 | Diabetic Ketoacidosis, Hypoglycaemia, Hypothermia, Renal Failure Acute, Rhabdomyolysis
on Sep 09, 2008 Male patient from JAPAN , 72 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Lispro (View Usage). Patient had the following side effects: diabetic ketoacidosis, hypoglycaemia, hypothermia (What is hypothermia?), renal failure acute, rhabdomyolysis. Lispro dosage: 8 Iu, Each Morning. During the same period patient was treated with HUMULIN N (10 Iu, Daily (1/d)) (View Humulin N Review and Humulin N Label ), AMLODIPINE (10 Mg, Unk) (View Amlodipine Review and Amlodipine Label ), CANDESARTAN (8 Mg, Unk) (View Candesartan Review and Candesartan Label ), TRICHLORMETHIAZIDE (1 Mg, Unk) (View Trichlormethiazide Review and Trichlormethiazide Label ). Patient was hospitalized.

5859934-3 | Blood Glucose Increased
on Aug 07, 2008 Male patient from AUSTRIA , 80 years of age, weighting 165.3 lb, was diagnosed with type 1 diabetes mellitus, blood pressure (What is blood pressure?) and was treated with Lispro (View Usage). After Lispro was administered, patient had the following side effects: blood glucose increased. Lispro dosage: 10 Iu, Each Morning. During the same period patient was treated with NEBIVOLOL HCL (2.5 Mg, 2/d) (View Nebivolol Hcl Review and Nebivolol Hcl Label ), RAMIPRIL (5 Mg, 2/d) (View Ramipril Review and Ramipril Label ), INEGY (1 D/f, Each Evening) (View Inegy Review and Inegy Label ), DOXIUM (500 Mg, 2/d) (View Doxium Review and Doxium Label ), TAMSULOSIN HCL (0.4 Mg, Daily (1/d)) (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), FURON (40 Mg, 2/d) (View Furon Review and Furon Label ).

5820912-1 | Diabetes Mellitus Inadequate Control, Diabetic Complication
Patient was taking Lispro (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes mellitus inadequate control, diabetic complication on Jul 10, 2008 from CROATIA (local name: Hrvatska) Additional patient health information: Female patient , weighting 169.8 lb, was diagnosed with type 1 diabetes mellitus, prophylaxis, dysmenorrhoea and. Lispro dosage: 26 Iu, Unk. During the same period patient was treated with INSULIN GLARGINE (15 Iu, Daily (1/d)) (View Insulin Glargine Review and Insulin Glargine Label ), TRANDOLAPRIL (View Trandolapril Review and Trandolapril Label ), ETHYLESTRENOL (View Ethylestrenol Review and Ethylestrenol Label ), VITAMINS NOS (View Vitamins Nos Review and Vitamins Nos Label ). Patient was hospitalized.

5806368-3 | Diabetes Mellitus Inadequate Control, Diabetic Complication
Adverse event was reported on Jun 27, 2008 by a Female patient taking Lispro (View Usage) (Dosage: 26 Iu, Unk) was diagnosed with type 1 diabetes mellitus, prophylaxis, dysmenorrhoea and. Location: CROATIA (local name: Hrvatska) , weighting 169.8 lb, Patient had the following side effects: diabetes mellitus inadequate control, diabetic complication. During the same period patient was treated with INSULIN GLARGINE (15 Iu, Daily (1/d)) (View Insulin Glargine Review and Insulin Glargine Label ), TRANDOLAPRIL (View Trandolapril Review and Trandolapril Label ), ETHYLESTRENOL (View Ethylestrenol Review and Ethylestrenol Label ), VITAMINS NOS (View Vitamins Nos Review and Vitamins Nos Label ). Patient was hospitalized.

5747538-2 | Diabetes Mellitus Inadequate Control, Diabetic Complication
on May 12, 2008 Female patient from CROATIA (local name: Hrvatska) , weighting 169.8 lb, was diagnosed with type 1 diabetes mellitus, prophylaxis, dysmenorrhoea and was treated with Lispro (View Usage). After Lispro was administered, patient had the following side effects: diabetes mellitus inadequate control, diabetic complication. Lispro dosage: 26 Iu, Unk. During the same period patient was treated with INSULIN GLARGINE (15 Iu, Daily (1/d)) (View Insulin Glargine Review and Insulin Glargine Label ), TRANDOLAPRIL (View Trandolapril Review and Trandolapril Label ), ETHYLESTRENOL (View Ethylestrenol Review and Ethylestrenol Label ), VITAMINS NOS (View Vitamins Nos Review and Vitamins Nos Label ). Patient was hospitalized.

5704553-2 | Diabetic Ketoacidosis
on Apr 01, 2008 Female patient from UNITED STATES , weighting 150.0 lb, was treated with Lispro (View Usage). Patient experienced the following unwanted or unexpected effects: diabetic ketoacidosis. Lispro dosage: 18 Iu, 3/d. During the same period patient was treated with INSULIN GLARGINE (26 Iu, Each Morning) (View Insulin Glargine Review and Insulin Glargine Label ).

5679472-0 | Diabetes Mellitus Inadequate Control, Diabetic Complication
Patient was taking Lispro (View Usage). Patient had the following side effects: diabetes mellitus inadequate control, diabetic complication on Mar 12, 2008 from CROATIA (local name: Hrvatska) Additional patient health information: Female patient , weighting 169.8 lb, was diagnosed with prophylaxis, dysmenorrhoea and. Lispro dosage: 26 Iu, Unk. During the same period patient was treated with INSULIN GLARGINE (15 Iu, Daily (1/d)) (View Insulin Glargine Review and Insulin Glargine Label ), TRANDOLAPRIL (View Trandolapril Review and Trandolapril Label ), ETHYLESTRENOL (View Ethylestrenol Review and Ethylestrenol Label ), VITAMINS NOS (View Vitamins Nos Review and Vitamins Nos Label ). Patient was hospitalized.

5660718-X | Lichen Planus
Adverse event was reported on Feb 29, 2008 by a Female patient taking Lispro (View Usage) (Dosage: 17 Iu, Each Morning) was diagnosed with diabetes mellitus and. Location: HUNGARY , 62 years of age, After Lispro was administered, patient had the following side effects: lichen planus. During the same period patient was treated with LEVEMIR (21 Iu, Each Morning) (View Levemir Review and Levemir Label ), PREDUCTAL (Unk, 2/d) (View Preductal Review and Preductal Label ), METFORMIN HCL (425 Mg, 2/d) (View Metformin Hcl Review and Metformin Hcl Label ), CRESTOR (20 Mg, Daily (1/d)) (View Crestor Review and Crestor Label ). Patient was hospitalized.

5657624-3 | Angina Pectoris
on Feb 25, 2008 Female patient from SLOVENIA , weighting 194.0 lb, was diagnosed with diabetes mellitus, hypertension, stent placement, coronary artery disease (What is coronary artery disease?) and was treated with Lispro (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris. Lispro dosage: 28 D/f 3/d. During the same period patient was treated with HUMULIN N (19 D/f, Daily (1/d)) (View Humulin N Review and Humulin N Label ), CORYOL (View Coryol Review and Coryol Label ), DIOVAN (80 Mg, Unk) (View Diovan Review and Diovan Label ), PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLARITIN (View Claritin Review and Claritin Label ). Patient was hospitalized.

5647202-4 | Diabetes Mellitus Inadequate Control, Diabetic Complication
on Feb 18, 2008 Female patient from CROATIA (local name: Hrvatska) , weighting 169.8 lb, was diagnosed with prophylaxis, dysmenorrhoea and was treated with Lispro (View Usage). Patient had the following side effects: diabetes mellitus inadequate control, diabetic complication. Lispro dosage: 26 Iu, Unk. During the same period patient was treated with INSULIN GLARGINE (15 Iu, Daily (1/d)) (View Insulin Glargine Review and Insulin Glargine Label ), TRANDOLAPRIL (View Trandolapril Review and Trandolapril Label ), ETHYLESTRENOL (View Ethylestrenol Review and Ethylestrenol Label ), VITAMINS NOS (View Vitamins Nos Review and Vitamins Nos Label ). Patient was hospitalized.

5632348-7 | Angina Pectoris
Patient was taking Lispro (View Usage). After Lispro was administered, patient had the following side effects: angina pectoris on Feb 05, 2008 from SLOVENIA Additional patient health information: Female patient , weighting 194.0 lb, was diagnosed with diabetes mellitus, hypertension, stent placement, coronary artery disease (What is coronary artery disease?) and. Lispro dosage: 28 Unk, 3/d. During the same period patient was treated with HUMULIN N (19 Unk, Daily (1/d)) (View Humulin N Review and Humulin N Label ), CORYOL (View Coryol Review and Coryol Label ), DIOVAN (80 Mg, Unk) (View Diovan Review and Diovan Label ), PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLARITIN (View Claritin Review and Claritin Label ). Patient was hospitalized.

5608265-5 | Hypoglycaemia, Loss Of Consciousness
Adverse event was reported on Jan 17, 2008 by a Male patient taking Lispro (View Usage) (Dosage: 26 Iu, Daily (1/d)) . Location: UNITED STATES , weighting 246.5 lb, Patient experienced the following unwanted or unexpected effects: hypoglycaemia, loss of consciousness. During the same period patient was treated with INSULIN GLARGINE (70 Iu, Daily (1/d)) (View Insulin Glargine Review and Insulin Glargine Label ), ASPIRIN (81 Mg, Daily (1/d)) (View Aspirin Review and Aspirin Label ), EZETIMIBE (10 Mg, Daily (1/d)) (View Ezetimibe Review and Ezetimibe Label ), SIMVASTATIN (40 Mg, Daily (1/d)) (View Simvastatin Review and Simvastatin Label ), FEXOFENADINE HYDROCHLORIDE (180 Mg, Daily (1/d)) (View Fexofenadine Hydrochloride Review and Fexofenadine Hydrochloride Label ), OMEPRAZOLE (20 Mg, Daily (1/d)) (View Omeprazole Review and Omeprazole Label ), RAMIPRIL (10 Mg, Daily (1/d)) (View Ramipril Review and Ramipril Label ).

5602303-1 | Cardiac Failure Congestive
on Jan 11, 2008 Male patient from CROATIA (local name: Hrvatska) , weighting 189.6 lb, was diagnosed with diabetes mellitus, angina pectoris, hyperlipidaemia and was treated with Lispro (View Usage). Patient had the following side effects: cardiac failure congestive. Lispro dosage: . During the same period patient was treated with ANDOL (100 Mg, Daily (1/d)) (View Andol Review and Andol Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), LESCOL (View Lescol Review and Lescol Label ). Patient was hospitalized.

5592004-0 | Diabetic Ketoacidosis
on Dec 31, 2007 Female patient from UNITED STATES , weighting 149.0 lb, was treated with Lispro (View Usage). After Lispro was administered, patient had the following side effects: diabetic ketoacidosis. Lispro dosage: 18 Iu, Other. During the same period patient was treated with INSULIN GLARGINE (25 Iu, Each Morning) (View Insulin Glargine Review and Insulin Glargine Label ).

5578928-9 | Cardiac Failure Congestive
Patient was taking Lispro (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive on Dec 18, 2007 from CROATIA (local name: Hrvatska) Additional patient health information: Male patient , weighting 189.6 lb, was diagnosed with diabetes mellitus, angina pectoris, hyperlipidaemia and. Lispro dosage: 16 Iu, Unk. During the same period patient was treated with ANDOL (100 Mg, Daily (1/d)) (View Andol Review and Andol Label ), ISOSORBIDE MONONITRATE (Unk, Unk) (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), LESCOL (Unk, Unk) (View Lescol Review and Lescol Label ). Patient was hospitalized.

5578926-5 | Diabetic Nephropathy, Pulmonary Oedema
Adverse event was reported on Dec 18, 2007 by a Female patient taking Lispro (View Usage) (Dosage: ) . Location: SLOVENIA , 67 years of age, Patient had the following side effects: diabetic nephropathy, pulmonary oedema. During the same period patient was treated with CIPROFLOXACIN HCL (200 Mg, Daily (1/d)) (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), HEPARIN (View Heparin Review and Heparin Label ), INSULIN (View Insulin Review and Insulin Label ), CHOLESTEROL AND TRIGLYCERIDE REDUCERS (View Cholesterol- And Triglyceride Reducers Review and Cholesterol- And Triglyceride Reducers Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), PENTOXIFYLLINE (View Pentoxifylline Review and Pentoxifylline Label ). Patient was hospitalized.

5567009-6 | Cardiac Failure, Cardiogenic Shock
on Dec 17, 2007 Female patient from SLOVENIA , weighting 154.3 lb, was diagnosed with diabetes mellitus, bronchitis (What is bronchitis?) and was treated with Lispro (View Usage). After Lispro was administered, patient had the following side effects: cardiac failure, cardiogenic shock. Lispro dosage: 24-8-10 Iu/kg, Daily (1/d). During the same period patient was treated with EDICIN (View Edicin Review and Edicin Label ), CEFOTAXIME (View Cefotaxime Review and Cefotaxime Label ). Patient was hospitalized.

5564510-6 | Uterine Polyp
on Dec 10, 2007 Female patient from POLAND , weighting 200.6 lb, was diagnosed with diabetes mellitus, angina pectoris, oedema peripheral, hypertension, prophylaxis and was treated with Lispro (View Usage). Patient experienced the following unwanted or unexpected effects: uterine polyp. Lispro dosage: 47 U, 3/d. During the same period patient was treated with SIMVAHEXAL (Unk, Unk) (View Simvahexal Review and Simvahexal Label ), EFFOX (Unk, Unk) (View Effox Review and Effox Label ), NITROMINT (Unk, Unk) (View Nitromint Review and Nitromint Label ), SPIRONOL (Unk, Unk) (View Spironol Review and Spironol Label ), TRITACE (Unk, Unk) (View Tritace Review and Tritace Label ), BISOCARD (Unk, Unk) (View Bisocard Review and Bisocard Label ), LACIPIL (Unk, Unk) (View Lacipil Review and Lacipil Label ). Patient was hospitalized.

5564502-7 | Diabetic Ketoacidosis
Patient was taking Lispro (View Usage). Patient had the following side effects: diabetic ketoacidosis on Dec 07, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 149.0 lb, . Lispro dosage: 18 Iu, Other. During the same period patient was treated with INSULIN GLARGINE (25 Iu, Each Morning) (View Insulin Glargine Review and Insulin Glargine Label ).

5564501-5 | Cardiac Failure, Cardiogenic Shock
Adverse event was reported on Dec 04, 2007 by a Female patient taking Lispro (View Usage) (Dosage: 24-8-10 Iu/kg, Daily (1/d)) was diagnosed with diabetes mellitus, bronchitis (What is bronchitis?) and. Location: SLOVENIA , weighting 154.3 lb, After Lispro was administered, patient had the following side effects: cardiac failure, cardiogenic shock. During the same period patient was treated with EDICIN (View Edicin Review and Edicin Label ). Patient was hospitalized.

5510537-X | Ascites, Dyspnoea Exertional, Face Oedema, Oedema Peripheral, Orthopnoea, Pleural Effusion
on Oct 29, 2007 Female patient from AUSTRALIA , 19 years of age, weighting 81.57 lb, was diagnosed with diabetes mellitus, diabetic ketoacidosis and was treated with Lispro (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, dyspnoea exertional, face oedema, oedema peripheral, orthopnoea, pleural effusion. Lispro dosage: 20-30 Iu Premeals. During the same period patient was treated with INSULIN DETEMIR (26 U, Each Evening Before Bed) (View Insulin Detemir Review and Insulin Detemir Label ).

5502075-5 | Fatigue, Loss Of Consciousness
on Oct 15, 2007 Male patient from UNITED STATES , weighting 246.5 lb, was diagnosed with type 1 diabetes mellitus and was treated with Lispro (View Usage). Patient had the following side effects: fatigue, loss of consciousness. Lispro dosage: 26 Iu, Daily (1/d). During the same period patient was treated with INSULIN GLARGINE (70 Iu, Daily (1/d)) (View Insulin Glargine Review and Insulin Glargine Label ), ASPIRIN (81 Mg, Daily (1/d)) (View Aspirin Review and Aspirin Label ), EZETIMIBE (10 Mg, Daily (1/d)) (View Ezetimibe Review and Ezetimibe Label ), SIMVASTATIN (40 Mg, Daily (1/d)) (View Simvastatin Review and Simvastatin Label ), FEXOFENADINE HYDROCHLORIDE (180 Mg, Daily (1/d)) (View Fexofenadine Hydrochloride Review and Fexofenadine Hydrochloride Label ), OMEPRAZOLE (20 Mg, Daily (1/d)) (View Omeprazole Review and Omeprazole Label ), RAMIPRIL (10 Mg, Daily (1/d)) (View Ramipril Review and Ramipril Label ).

5499593-5 | Thrombocytopenia, Uterine Polyp
Patient was taking Lispro (View Usage). After Lispro was administered, patient had the following side effects: thrombocytopenia, uterine polyp on Oct 12, 2007 from POLAND Additional patient health information: Female patient , weighting 200.6 lb, was diagnosed with diabetes mellitus, angina pectoris, oedema peripheral, hypertension, prophylaxis and. Lispro dosage: 47 U, 3/d. During the same period patient was treated with SIMVAHEXAL (Unk, Unk) (View Simvahexal Review and Simvahexal Label ), EFFOX (Unk, Unk) (View Effox Review and Effox Label ), NITROMINT (Unk, Unk) (View Nitromint Review and Nitromint Label ), SPIRONOL (Unk, Unk) (View Spironol Review and Spironol Label ), TRITACE (Unk, Unk) (View Tritace Review and Tritace Label ), BISOCARD (Unk, Unk) (View Bisocard Review and Bisocard Label ), LACIPIL (Unk, Unk) (View Lacipil Review and Lacipil Label ). Patient was hospitalized.

5482252-2 | Altered State Of Consciousness, Cardio-respiratory Arrest, Diabetic Foot, Dizziness, Fall, Fatigue, Foot Amputation, Gangrene, Hypoglycaemia
Adverse event was reported on Sep 27, 2007 by a Female patient taking Lispro (View Usage) (Dosage: 48 U, Daily (1/d)) was diagnosed with type 2 diabetes mellitus and. Location: INDIA , weighting 149.9 lb, Patient experienced the following unwanted or unexpected effects: altered state of consciousness, cardio-respiratory arrest, diabetic foot, dizziness (What is dizziness?), fall (What is fall?), fatigue, foot amputation, gangrene, hypoglycaemia. During the same period patient was treated with LANTUS (52 U, Each Evening) (View Lantus Review and Lantus Label ), METFORMIN HCL (500 Mg, 3/d) (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

5448454-6 | Diabetic Foot
on Aug 27, 2007 Female patient from INDIA , 56 years of age, weighting 149.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with Lispro (View Usage). Patient had the following side effects: diabetic foot. Lispro dosage: 48 U, Daily (1/d). During the same period patient was treated with METFORMIN HCL (500 Mg, 3/d) (View Metformin Hcl Review and Metformin Hcl Label ), LANTUS (52 U, Unk) (View Lantus Review and Lantus Label ). Patient was hospitalized.

5409006-7 | Hypoglycaemia, Road Traffic Accident
on Jul 26, 2007 Female patient from UNITED STATES , 41 years of age, weighting 143.0 lb, was diagnosed with diabetes mellitus, hypertension, blood cholesterol increased, prophylaxis and was treated with Lispro (View Usage). After Lispro was administered, patient had the following side effects: hypoglycaemia, road traffic accident. Lispro dosage: 18 Iu, Daily (1/d). During the same period patient was treated with *INSULIN GLARGINE (42 Iu, Daily (1/d)) (View *insulin Glargine Review and *insulin Glargine Label ), ALTACE (View Altace Review and Altace Label ), COREG (View Coreg Review and Coreg Label ), ZOCOR (View Zocor Review and Zocor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5409005-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Chest Pain, Cystitis, Diabetic Ketoacidosis, Electrocardiogram Abnormal, Electrocardiogram Poor R-wave Progression, Gastroenteritis, Glycosylated Haemoglobin Increased
Patient was taking Lispro (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, chest pain (What is chest pain?), cystitis, diabetic ketoacidosis, electrocardiogram abnormal, electrocardiogram poor r-wave progression, gastroenteritis (What is gastroenteritis?), glycosylated haemoglobin increased on Jul 25, 2007 from UNITED STATES Additional patient health information: Female patient , 23 years of age, weighting 152.0 lb, was diagnosed with diabetes mellitus, depression (What is depression?), cystitis and. Lispro dosage: 36 Iu, 3/d. During the same period patient was treated with *INSULIN GLARGINE (40 Iu, Daily (1/d)) (View *insulin Glargine Review and *insulin Glargine Label ), PROZAC (View Prozac Review and Prozac Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ). Patient was hospitalized.

5401877-3 | Abdominal Distension, Dizziness, Headache, Nausea
Adverse event was reported on Jul 23, 2007 by a Female patient taking Lispro (View Usage) (Dosage: Higher Dose Of 6 U When Bg {300 Mg/dl) was diagnosed with diabetes mellitus and. Location: PORTUGAL , 17 years of age, Patient had the following side effects: abdominal distension, dizziness (What is dizziness?), headache (What is headache?), nausea (What is nausea?). During the same period patient was treated with HUMULIN N (View Humulin N Review and Humulin N Label ), ACTRAPID INSULIN NOVO (View Actrapid Insulin Novo Review and Actrapid Insulin Novo Label ).

5399501-1 | Hypoglycaemia, Road Traffic Accident
on Jul 13, 2007 Female patient from UNITED STATES , 41 years of age, weighting 143.0 lb, was diagnosed with diabetes mellitus, hypertension, blood cholesterol increased, prophylaxis and was treated with Lispro (View Usage). After Lispro was administered, patient had the following side effects: hypoglycaemia, road traffic accident. Lispro dosage: 18 Iu, Daily (1/d). During the same period patient was treated with *INSULIN GLARGINE (42 Iu, Daily (1/d)) (View *insulin Glargine Review and *insulin Glargine Label ), ALTACE (View Altace Review and Altace Label ), COREG (View Coreg Review and Coreg Label ), ZOCOR (View Zocor Review and Zocor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5367823-6 | Diabetic Ketoacidosis
on May 25, 2007 Female patient from UNITED STATES , 23 years of age, weighting 152.0 lb, was diagnosed with diabetes mellitus, depression (What is depression?), cystitis and was treated with Lispro (View Usage). Patient experienced the following unwanted or unexpected effects: diabetic ketoacidosis. Lispro dosage: 36 Iu, 3/d. During the same period patient was treated with *INSULIN GLARGINE (40 Iu, Daily (1/d)) (View *insulin Glargine Review and *insulin Glargine Label ), PROZAC (View Prozac Review and Prozac Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ). Patient was hospitalized.

5365639-8 | Abdominal Distension, Dizziness, Nausea
Patient was taking Lispro (View Usage). Patient had the following side effects: abdominal distension, dizziness (What is dizziness?), nausea (What is nausea?) on Jun 11, 2007 from PORTUGAL Additional patient health information: Female patient , 17 years of age, was diagnosed with diabetes mellitus and. Lispro dosage: 5 Times Daily. During the same period patient was treated with HUMULIN N (View Humulin N Review and Humulin N Label ), ACTRAPID INSULIN NOVO (View Actrapid Insulin Novo Review and Actrapid Insulin Novo Label ).